Nationally, she sits on the board of the French clinical trial intergroup, GINECO, and is President of the GiNEGEPS (GINECO group on Early Phase Studies). Internationally, she is a member of the ENGOT translational research group, a French representative at the GCIG (Gynecological Cancers InterGroup), and co-chair the GCIG phase II trial group.